Discover Baxter International's Q4 2024 earnings insights, including recovery milestones, Novum IQ pump success, and a promising 2025 growth outlook.

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. On its fourth attempt to pass muster with the FDA, the company’s SPN-830 ...

He will serve in an advisory capacity through Oct. 31, 2025. The Baxter Board of Directors has appointed lead independent director Brent Shafer as chair and interim CEO and has initiated a search ...

Baxter President and CEO José Almeida has announced his retirement, effective immediately, after nearly a decade of leading the medtech company. The news comes just days after Baxter completed ...

DEERFIELD, Ill., February 03, 2025--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that José (Joe) E. Almeida, chair, president and chief ...

DEERFIELD, Ill., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Vantive, formerly the Baxter Kidney Care segment, today launched as a new standalone vital organ therapy company following the completion of its ...

Feb 3 (Reuters) - Medical products maker Baxter International (BAX.N), opens new tab said on Monday its CEO José Almeida will retire effective immediately, after nearly a decade as the company's ...

The FDA (7) classifies adverse events related to infusion pumps according to their cause: software problems, alarm errors, inadequate user interface design (“human factors” problems), broken ...

Baxter International seems pretty uncompelling as an investment opportunity, and investors should look elsewhere. Even so, within each business segment, we see there are different important ...

The reverse takeover of Sigma Healthcare, a wholesaler and franchiser with brands such as Amcal and Discount Drug Stores, has taken more than a year to be approved by regulators and finally ...

The announcement drove Sigma shares 7.8 per cent higher in early trade on Tuesday to $2.91. Sigma shareholders are sitting on outsized gains since the proposed merger was announced on December 6 ...

BD (NYSE: BDX) + plans to close a facility in Caesarea, Israel, by the middle of the year. BD continuously reviews its global manufacturing and supply chain network to optimize operations and ...